<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Barr</title>
<description>International Business News - Barr</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Barr Pharmaceuticals spent $1.7M lobbying in 1Q</title>
  <description>Generic drug maker Barr Pharmaceuticals Inc. spent nearly $1.7 million in the first quarter lobbying on legislation affecting the drug industry, according to a recent disclosure form.</description>
    <link>http://www.ibtimes.com/articles/20080627/barr-pharmaceuticals-spent-1-7m-lobbying-in-1q.htm</link> 
  <pubDate>Fri, 27 Jun 2008 16:05:51 EDT</pubDate>
  </item>


  <item>
  <title>Movers roundup: Barr Pharmaceuticals, Palm</title>
  <description>Among the stock activity stories for Friday, June 27, from AP Financial News: NEW YORK (AP)--Shares of Barr Pharmaceuticals Inc. rose Friday as a Delaware federal court invalidated several patents covering Boehringer Ingelheim Pharmaceuticals Inc.&amp;#39;s Mirapex, opening the door for a generic launch.</description>
    <link>http://www.ibtimes.com/articles/20080627/movers-roundup-barr-pharmaceuticals-palm.htm</link> 
  <pubDate>Fri, 27 Jun 2008 14:40:19 EDT</pubDate>
  </item>


  <item>
  <title>Barr shares rise on Mirapex patent case victory</title>
  <description>Shares of Barr Pharmaceuticals Inc. rose Friday as a Delaware federal court invalidated several patents covering Boehringer Ingelheim Pharmaceuticals Inc.&amp;#39;s Mirapex, opening the door for a generic launch.</description>
    <link>http://www.ibtimes.com/articles/20080627/barr-shares-rise-on-mirapex-patent-case-victory.htm</link> 
  <pubDate>Fri, 27 Jun 2008 12:38:40 EDT</pubDate>
  </item>


  <item>
  <title>Barr scores victory in patent challenge on Mirapex</title>
  <description>Generic drug maker Barr Pharmaceuticals Inc. said late Thursday it won a patent challenge regarding Boehringer Ingelheim Pharmaceuticals Inc.&amp;#39;s drug Mirapex, increasing the possibility of a generic launch.</description>
    <link>http://www.ibtimes.com/articles/20080627/barr-scores-victory-in-patent-challenge-on-mirapex.htm</link> 
  <pubDate>Fri, 27 Jun 2008 10:54:45 EDT</pubDate>
  </item>


  <item>
  <title>Barr shares rise on Bayer birth control pills deal</title>
  <description>Shares of Barr Pharmaceuticals Inc. rose Tuesday after the generic drug company announced an agreement to sell two Bayer birth control pills years before the last patents expire on the products.</description>
    <link>http://www.ibtimes.com/articles/20080624/barr-shares-rise-on-bayer-birth-control-pills-deal.htm</link> 
  <pubDate>Tue, 24 Jun 2008 12:24:56 EDT</pubDate>
  </item>


  <item>
  <title>Barr to sell generic Bayer birth control pills</title>
  <description>Generic drug maker Barr Pharmaceuticals Inc. said Tuesday it signed an agreement with German pharmaceutical company Bayer AG to sell a generic version of the birth control pill Yasmin on or before July 1, several years before the last patent on the product expires.</description>
    <link>http://www.ibtimes.com/articles/20080624/barr-to-sell-generic-bayer-birth-control-pills.htm</link> 
  <pubDate>Tue, 24 Jun 2008 08:00:11 EDT</pubDate>
  </item>


  <item>
  <title>GOP frets Barr could play spoiler in prez race</title>
  <description>A fiery former GOP congressman who gained national prominence for doggedly pursuing impeachment of President Clinton has some Republicans worried he&amp;#39;ll play spoiler in a tight presidential contest.</description>
    <image>
  <url>http://www.ibtimes.com/data/articleimgs/77158-bob-barr.jpg</url>
  <link>http://www.ibtimes.com/articles/20080622/gop-frets-barr-could-play-spoiler-in-prez-race.htm</link>
  </image>
    <link>http://www.ibtimes.com/articles/20080622/gop-frets-barr-could-play-spoiler-in-prez-race.htm</link> 
  <pubDate>Sun, 22 Jun 2008 15:10:22 EDT</pubDate>
  </item>


  <item>
  <title>Barr sued for alleged patent infringement</title>
  <description>Barr Pharmaceuticals Inc. said Tuesday it is being sued by Japan-based Takeda Pharmaceutical Co. and TAP Pharmaceuticals Inc. for alleged patent infringement of a patent covering the antacid Prevacid.</description>
    <link>http://www.ibtimes.com/articles/20080610/barr-sued-for-alleged-patent-infringement.htm</link> 
  <pubDate>Tue, 10 Jun 2008 17:13:55 EDT</pubDate>
  </item>


  <item>
  <title>AstraZeneca suing Barr over bowel disease drug</title>
  <description>Barr Pharmaceuticals Inc. said Tuesday it is being sued by AstraZeneca PLC in a patent dispute over the inflammatory bowel disease drug Entocort. Montvale, N.J.-based Barr is challenging the patent on the drug. It asked the Food and Drug Administration to approve a generic version in January.</description>
    <link>http://www.ibtimes.com/articles/20080527/astrazeneca-suing-barr-over-bowel-disease-drug.htm</link> 
  <pubDate>Tue, 27 May 2008 17:06:45 EDT</pubDate>
  </item>


  <item>
  <title>S&amp;P puts Barr Pharmaceuticals on credit watchlist</title>
  <description>Standard &amp; Poor&amp;#39;s Ratings Services said Friday it placed Barr Pharmaceuticals Inc. on its credit watchlist after the drug maker&amp;#39;s first-quarter profit came in below Wall Street expectations.</description>
    <link>http://www.ibtimes.com/articles/20080509/s-p-puts-barr-pharmaceuticals-on-credit-watchlist.htm</link> 
  <pubDate>Fri, 09 May 2008 14:44:01 EDT</pubDate>
  </item>


  <item>
  <title>Barr Pharma shares drop after guidance cut, downgrade</title>
  <description>Shares of Barr Pharmaceuticals Inc. plunged Thursday after the drug developer reported first-quarter profit below Wall Street expectations and slashed its 2008 forecast, leading at least one analyst to downgrade the stock.</description>
    <link>http://www.ibtimes.com/articles/20080508/barr-pharma-shares-drop-after-guidance-cut-downgrade.htm</link> 
  <pubDate>Thu, 08 May 2008 12:54:44 EDT</pubDate>
  </item>


  <item>
  <title>Barr Pharmaceuticals lowers 2008 forecast</title>
  <description>Barr Pharmaceuticals Inc. slashed its 2008 forecast Thursday after reporting that first-quarter earnings failed to meet expectations as the company&amp;#39;s U.S. generic contraceptive sales fell.</description>
    <link>http://www.ibtimes.com/articles/20080508/barr-pharmaceuticals-lowers-2008-forecast.htm</link> 
  <pubDate>Thu, 08 May 2008 08:42:10 EDT</pubDate>
  </item>


  <item>
  <title>Barr CEO&amp;#39;s 2007 Compensation Falls</title>
  <description>
Barr Pharmaceuticals Chief Executive Bruce L. Downey received less compensation in 2007 on a cut in stock options and restricted stock units, according to the generic drug company&amp;#39;s proxy statement ...</description>
    <link>http://www.ibtimes.com/articles/20080408/barr-ceos-2007-compensation-falls.htm</link> 
  <pubDate>Tue, 08 Apr 2008 10:34:48 EDT</pubDate>
  </item>


  <item>
  <title>Ex-Congressman Explores Presidential Bid</title>
  <description>
Former Republican Congressman Bob Barr says he&amp;#39;s formed a presidential exploratory committee and may seek the Libertarian party nomination.

Barr says in a news release that he told Midwestern polit...</description>
    <link>http://www.ibtimes.com/articles/20080405/ex-congressman-explores-presidential-bid.htm</link> 
  <pubDate>Sat, 05 Apr 2008 16:34:10 EDT</pubDate>
  </item>


  <item>
  <title>Ex-Congressman Weighs Presidential Bid</title>
  <description>
Former Republican congressman Bob Barr is hinting strongly that he&amp;#39;ll jump into the presidential race as a Libertarian.

Barr, 59, who left the GOP in 2006 over what he called bloated spending and c...</description>
    <link>http://www.ibtimes.com/articles/20080404/ex-congressman-weighs-presidential-bid.htm</link> 
  <pubDate>Fri, 04 Apr 2008 17:10:47 EDT</pubDate>
  </item>


  <item>
  <title>Barr Shares Rise on Lehman Outlook</title>
  <description>
Shares of drug developer Barr Pharmaceuticals Inc. rose Friday after Lehman Brothers reaffirmed an "Overweight" rating on the company, citing its near- to medium-term outlook.

The stock rose $1.81, ...</description>
    <link>http://www.ibtimes.com/articles/20080404/barr-shares-rise-on-lehman-outlook.htm</link> 
  <pubDate>Fri, 04 Apr 2008 14:56:06 EDT</pubDate>
  </item>


  <item>
  <title>Barr's Generic Cancer Drug Approved</title>
  <description>Drug developer Barr Pharmaceuticals Inc. said Wednesday it received final Food and Drug Administration approval for a generic version of Bristol-Myers Squibb Co.'s cancer treatment Taxol.</description>
    <link>http://www.ibtimes.com/articles/20080312/barrs-generic-cancer-drug-approved.htm</link> 
  <pubDate>Wed, 12 Mar 2008 15:08:37 EDT</pubDate>
  </item>


  <item>
  <title>Barr Files Patent Suit Against Watson</title>
  <description>Drug developer Barr Pharmaceuticals Inc. said Wednesday it has filed a lawsuit against branded and generic drug maker Watson Pharmaceuticals Inc. for infringement of its patent on birth-control pill Seasonique.</description>
    <link>http://www.ibtimes.com/articles/20080305/barr-files-patent-suit-against-watson.htm</link> 
  <pubDate>Wed, 05 Mar 2008 11:32:39 EST</pubDate>
  </item>


  <item>
  <title>Barr Shares Jump on Patent Dispute Win</title>
  <description>Shares of Barr Pharmaceuticals Inc. jumped Tuesday as Wall Street predicted the drug developer would gain more revenue from generic sales of the birth-control pill Yasmin following a patent dispute victory.</description>
    <link>http://www.ibtimes.com/articles/20080304/barr-shares-jump-on-patent-dispute-win.htm</link> 
  <pubDate>Tue, 04 Mar 2008 12:32:37 EST</pubDate>
  </item>


  <item>
  <title>Barr Claims Win in Patent Dispute</title>
  <description>Drug developer Barr Pharmaceuticals Inc. said Monday a federal judge ruled in its favor in a patent dispute over the oral contraceptive Yasmin with Bayer Schering Pharma AG.</description>
    <link>http://www.ibtimes.com/articles/20080304/barr-claims-win-in-patent-dispute.htm</link> 
  <pubDate>Tue, 04 Mar 2008 06:39:17 EST</pubDate>
  </item>


</channel>
</rss>